Fluoxetine
Product Images NDC 70934-833

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fluoxetine (NDC 70934-833). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 833 30 Master Bottle Label Approval Rev A 03 21)

Label (70934 833 30 Master Bottle Label Approval   Rev A 03 21)
Fluoxetine Capsules, USP 20 mg label for a bottle containing 30 capsules. The label includes directions to see the package insert for dosage, storage instructions to keep the bottle at 20°-25°C (68°-77°F), protect from moisture, and keep tightly closed. The label states the product is Rx only and manufactured by Denton Pharma, Inc. DBA Northwind Pharmaceuticals with NDC 70934-833-30.*
FDA Label Image

Chemical Structure (Fluoxetine Str)

Chemical Structure (Fluoxetine Str)
Chemical structure of fluoxetine hydrochloride, showing a trifluoromethyl phenyl group connected via an ether linkage to a side chain with amine and phenyl substituents, along with the hydrochloride salt component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.